Companies
Memorial Sloan Kettering
the largest long-term-survival clinical datasets.
- Country
- United States
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Comprehensive Cancer Center designated by the National Cancer Institute | cancer.gov |
| Research focus | Basic, translational, and clinical cancer research, including cancer biology, genetics, cell biology, computational biology, immunology, molecular biology, pharmacology, and structural biology | cancer.gov |
| Facility | Sloan Kettering Institute, Advanced Computing and Oncology Lab, Mortimer B. Zuckerman Research Center, Evelyn H. Lauder Breast Center, Josie Robertson Surgery Center, David H. Koch Center for Cancer Care, Bendheim Integrative Medicine Center, New York Proton Center (partnership), and various Sarcoma Center resources including a soft tissue sarcoma database and tissue bank | mskcc.org |
| Grant | Funded by National Cancer Institute (NCI), National Institutes of Health (NIH), Cycle for Survival, Kristen Ann Carr Fund, The Starr Foundation, David Geffen, Kenneth C. Griffin, and other institutional/external grants; total funding reported as $102.3M | mskcc.org |
| Principal staff | Includes CEO, directors of SKI, clinical research leads, and principal investigators like Dr. Tafadzwa L. Chaunzwa, Dr. Nikolaus Schultz, and Dr. Joan Massagué | mskcc.org |
| Headcount | Total staff of approximately 21,175, including 12,733 employees and over 1,200 physicians | mskcc.org |
Independent sources: cancer.gov · mskcc.org
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| TIL therapy (tumor-infiltrating lymphocytes) | therapeutics-platforms | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.